Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Minority Interest (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Minority Interest for 4 consecutive years, with -$83262.0 as the latest value for Q3 2025.

  • On a quarterly basis, Minority Interest fell 8.55% to -$83262.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$83262.0, a 8.55% decrease, with the full-year FY2024 number at -$80594.0, down 11.88% from a year prior.
  • Minority Interest was -$83262.0 for Q3 2025 at 60 Degrees Pharmaceuticals, down from -$82550.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of -$38105.0 in Q3 2023 to a low of -$576829.0 in Q2 2023.
  • A 4-year average of -$164933.5 and a median of -$80594.0 in 2024 define the central range for Minority Interest.
  • Peak YoY movement for Minority Interest: soared 87.41% in 2023, then plummeted 101.3% in 2024.
  • 60 Degrees Pharmaceuticals' Minority Interest stood at -$572320.0 in 2022, then skyrocketed by 87.41% to -$72038.0 in 2023, then fell by 11.88% to -$80594.0 in 2024, then dropped by 3.31% to -$83262.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Minority Interest are -$83262.0 (Q3 2025), -$82550.0 (Q2 2025), and -$81346.0 (Q1 2025).